Ultrafast CT developer Imatron has revised its product development and distribution agreementwith Siemens, the South San Francisco, CA, company reported lastweek. Under the terms of the new deal, Siemens will contribute$15 million toward a three-year
Ultrafast CT developer Imatron has revised its product development and distribution agreementwith Siemens, the South San Francisco, CA, company reported lastweek. Under the terms of the new deal, Siemens will contribute$15 million toward a three-year collaborative research programto upgrade Imatron's C-150 CT scanner, marketed by Siemens asEvolution EBT. Siemens will also cancel a $4 million loan to Imatronfor the transfer of Imatron patents to Siemens.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.